Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
170.90    -3.10 (-1.78%)
Bid:
171.10
Ask:
171.40
Spread: 0.30 (0.175%)
Market Cap: £755.86m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Directorate Change

3 Jun 2024 07:00

RNS Number : 7499Q
Pets At Home Group Plc
03 June 2024
 

 

 

FOR IMMEDIATE RELEASE 3 June 2024

Pets at Home Group Plc: Directorate Change

Pets at Home Group plc, the UK's leading pet care business, announces a change to its Board of Directors with the appointment of a new independent Non-Executive Director.

Garret Turley will be appointed as an independent Non-Executive Director with effect from 12 July 2024.

 

On appointment to the Board, Garret will also become a member of the Nomination and Corporate Governance Committee and will chair the ESG Committee.

 

Garret is a qualified veterinarian who co-founded and built Pet Doctors, after which he transitioned into private equity at Bridges Ventures where his focus was on health and education investments. Garret then joined August Equity as a Partner, where his role focused on the healthcare, social care and education sectors through strategic investments. Garret has significant board experience and currently chairs a privately owned social care business Koala Care, is a Non- Executive Director at Dunrogan on a family office board in his native Northern Ireland and chairs Blackrose, a boutique corporate advisory house.

 

Ian Burke, Chair of Pets at Home, commented:

"On behalf of the Board, I am delighted to welcome Garret Turley to Pets at Home Group plc. Garret has excellent experience in the veterinary sector and will bring strong strategic knowledge in this area, which continues to be a key part of the group's strategy. The directors and I look forward to Garret joining in July."

This disclosure is given in accordance with Listing Rule 9.6.11.

 

 

Enquiries

Pets at Home Group Plc:

Lesley Lazenby, Company Secretary

+44 (0)161 468 6688

 

Investor Relations/Media Enquiries Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations+44 (0)161 468 6688

Natalie Cullington, Head of Media & Corporate Affairs +44 (0)161 468 6688

 

About Pets At Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 440 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: https://www.petsathomeplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFIIRIIFIIS
Date   Source Headline
9th Jan 20195:17 pmRNSHolding(s) in Company
20th Dec 20187:00 amRNSExecutive Management Team Appointment
19th Dec 20185:20 pmRNSHolding(s) in Company
27th Nov 20187:00 amRNSInterim Financial Results
1st Nov 20187:00 amRNSExecutive Management Team Appointments
15th Oct 201811:21 amRNSChange in Director's details
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
12th Oct 201811:37 amRNSDirector/PDMR Shareholding
10th Oct 20187:00 amRNSExecutive Management Team Changes
9th Oct 201812:54 pmRNSHolding(s) in Company
5th Oct 20182:37 pmRNSHolding(s) in Company
3rd Oct 20187:00 amRNSSegmental Reporting Information
1st Oct 201812:34 pmRNSDirector/PDMR Shareholding
14th Sep 20184:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSQ1 Trading Statement
2nd Aug 20182:48 pmRNSHolding(s) in Company
19th Jul 201812:05 pmRNSDirector/PDMR Shareholding
12th Jul 20182:54 pmRNSResult of AGM
6th Jul 20187:09 amRNSHolding(s) in Company
6th Jul 20187:06 amRNSHolding(s) in Company
6th Jul 20187:00 amRNSHolding(s) in Company
5th Jul 201812:10 pmRNSHolding(s) in Company
4th Jul 20184:01 pmRNSHolding(s) in Company - Replacement
2nd Jul 20185:32 pmRNSHolding(s) in Company
2nd Jul 20185:31 pmRNSHolding(s) in Company
25th Jun 20182:37 pmRNSHolding(s) in Company
22nd Jun 20187:00 amRNSHolding(s) in Company
21st Jun 20184:09 pmRNSHolding(s) in Company
19th Jun 20182:02 pmRNSDirector/PDMR Shareholding
18th Jun 20186:11 pmRNSHolding(s) in Company
18th Jun 20186:11 pmRNSHolding(s) in Company
18th Jun 20182:15 pmRNSHolding(s) in Company
15th Jun 20185:33 pmRNSHolding(s) in Company
15th Jun 20182:04 pmRNSHolding(s) in Company
15th Jun 20187:07 amRNSHolding(s) in Company
15th Jun 20187:06 amRNSHolding(s) in Company
12th Jun 20183:14 pmRNSDirector/PDMR Shareholding
8th Jun 20184:29 pmRNSNotice of AGM
8th Jun 201812:30 pmRNSDirector/PDMR Shareholding
8th Jun 201812:28 pmRNSDirector/PDMR Shareholding
8th Jun 201812:27 pmRNSDirector/PDMR Shareholding
24th May 201811:27 amRNSDirector/PDMR Shareholding
24th May 201811:26 amRNSDirector/PDMR Shareholding
24th May 201811:25 amRNSDirector/PDMR Shareholding
24th May 201811:23 amRNSDirector/PDMR Shareholding
24th May 201811:17 amRNSDirector/PDMR Shareholding
24th May 201811:15 amRNSHolding(s) in Company
23rd May 20183:44 pmRNSHolding(s) in Company
23rd May 20181:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.